Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1366 of 5804
-
Scientists probe the mysterious crash that defines ME/CFS
Knowledge-focused Recruiting nowExercise is an important contributor to general health and is considered a potential remedy for chronic diseases. This is in strong contrast with the observation that in most myalgic encephalomyelitis (ME/CFS) patients exercise aggravates their symptoms. Recently, post-exertional…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
No needle needed? new trial tests oral COVID and flu vaccines together
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of the current study is to assess the effectiveness of protein-based COVID-19 or influenza vaccines when given individually or together via oral/ sublingual mucosal route instead of intramuscular delivery. The comparator will be a seasonal influenza vaccine which will…
Phase: PHASE1 • Sponsor: Vaxine Pty Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:28 UTC
-
Could a tongue-stimulating device help stroke survivors regain their balance?
Symptom relief OngoingPrimary Objective: To further evaluate the aspects of safety related to PoNS therapy in chronic stroke survivors. Secondary Objectives: To further evaluate the efficacy of PoNS on improving dynamic gait and balance, establishing durability of effect, risk of falling and fall rat…
Phase: NA • Sponsor: Helius Medical Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
AI could revolutionize heart valve surgery predictions
Knowledge-focused Recruiting nowThis non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Genetic showdown: can full genome sequencing outsmart rare gut disease?
Diagnosis Recruiting nowThis study will seek to determine if whole genome sequencing (WGS) improves diagnostic rates, and outcomes for congenital diarrhea and enteropathy (CODE) patients. The investigator will enroll 180 patients in a randomized controlled study to either WGS or whole exome sequencing (…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
HHT nosebleed drug shows promise in long-term follow-up study
Disease control CompletedThis is a multicenter U.S. longitudinal study evaluating patients with hereditary hemorrhagic telangiectasia who participated in the PATH-HHT clinical trial of pomalidomide for the treatment of HHT. This study is a longitudinal assessment of safety and effectiveness of pomalidomi…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Play heals: simple program eases anxiety in Quake-Hit tots
Symptom relief CompletedThe aim of this study was to evaluate the effectiveness of the Therapeutic Play-Based Intervention Programme (TOTEM), which was developed to reduce the negative psychosocial effects of the earthquake in children aged 4-6 years, and its effect on children's psychosocial well-being…
Phase: NA • Sponsor: Kocaeli University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Could a One-Time injection of your own immune cells protect your kidneys?
Disease control OngoingThe goal of this single-arm, open-label clinical trial is to evaluate the effects of subcutaneous autologous dendritic cell (DC) and lymphocyte administration on albuminuria and endothelial dysfunction in Type 2 Diabetes Mellitus (T2DM) patients with Diabetic Kidney Disease (DKD)…
Phase: PHASE1, PHASE2 • Sponsor: PT. JES Kasih Nusantara Sejahterah • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Ear-Zap hope: new device may spark awakening in Brain-Injured patients
Symptom relief Recruiting nowConsciousness disorders following severe brain injury refer to a series of disturbances in arousal and cognition secondary to organic brain diseases, including Unresponsive Wakefulness Syndrome (UWS) (also termed Vegetative State, VS) and Minimally Conscious State (MCS). Disorder…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New online program aims to ease chronic pancreatitis pain
Symptom relief Recruiting nowSevere and disabling abdominal pain is common in individuals with chronic pancreatitis. Although pain is associated with reduced quality of life and high economic and societal costs, there are limited effective options for pain management in this population. This study proposes a…
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could a $4 statin be the migraine cure We've been missing?
Disease control Recruiting nowThe main objective of this study is to see whether the favorable preventative effect of Atorvastatin 40mg per day in episodic migraine, that was found previously in three smaller randomized controlled cross-over studies, can be confirmed in a larger, multicenter, randomized contr…
Phase: PHASE2 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Balloon in the womb: new hope for babies with severe birth defect?
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
Phase: NA • Sponsor: Rodrigo Ruano • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a single ketamine shot curb suicidal urges in the ER?
Symptom relief Recruiting nowThere is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression,…
Phase: PHASE1 • Sponsor: Lindsay Maguire, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Brain pacemaker shows promise for rare childhood epilepsy
Disease control OngoingThe primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of pallidothalamic tracts as adjunctive therapy for alleviating symptoms in Lennox-Gastaut Syndrome.
Phase: NA • Sponsor: Liankun_Ren • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Mobile clinic brings prenatal care to marshallese moms, aims to reduce preterm births
Disease control CompletedPacific Islanders bear a disproportionate burden of obesity compared to other racial/ethnic minorities and the United States (US) population. Pacific Islanders residing in the US also have high maternal and infant health disparities with disproportionally high rates of preterm bi…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Malaria drug resistance confirmed in ethiopia: study raises alarm
Knowledge-focused CompletedArtemisinin-based combination therapies (ACTs) are the main treatment for falciparum malaria in Africa. Artemisinin partial resistance (ART-R), characterized by delayed parasite clearance after treatment, has been confirmed in four sub-Saharan African countries. In Ethiopia, mole…
Phase: NA • Sponsor: Didier Menard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New drug cocktail aims to slow kidney disease
Disease control CompletedThe purpose of the study is to evaluate the efficacy, safety and tolerability of balcinrenone/dapagliflozin compared with dapagliflozin alone on patients with chronic kidney disease (CKD) and albuminuria. This study will evaluate the effect of the balcinrenone/dapagliflozin on ur…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug camoteskimab tested for Tough-to-Treat eczema
Disease control CompletedThis is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
Could a hormone and a sleep aid prevent brain surgery in preemies?
Disease control Recruiting nowVery preterm infants are prone to numerous medical complications with lifelong impact. Amongst the most serious neurologically are white matter injury (WMI), intraventricular hemorrhage (IVH) and the subsequent progression to posthemorrhagic hydrocephalus (PHH). Currently, the on…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a single burst of magnetic pulses lift depression in autism?
Symptom relief Recruiting nowThis study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potent…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC